Ottawa, August 13, 2018 — Cannabis legalization in Canada is less than 75 days away. What can we expect when this happens?
A class of medications used to treat type 2 diabetes and obesity could help treat substance use disorders. GLP-1s, made popular by brands like Ozempic and Wegovy, show real promise in helping people curb cravings for substances like alcohol and…
Ottawa, June 26, 2018 — Today, with the United Nations, governments, NGOs and citizens from around the world, the Canadian Centre on Substance Use and Addiction (CCSA) is proud to recognize the…
Ottawa, Dec. 14, 2021 — Youth across Canada are reporting higher levels of anxiety and substance use concerns, with less ability to handle pandemic stress.
Myran, D., Tanuseputro, P., Auger, N., Konikoff, L., Talarico, R., Finkelstein, Y., Gaudreault, A., Pacula, R.
Ottawa, February 25, 2019 — In a brief submitted to Health Canada’s consultation on Strict regulation of edible cannabis, extracts and topicals, the Canadian Centre on Substance Use and Addiction (CCSA) cautions that edible…
Substance Use Costs in Canada rose to $49.1 billion in 2020
Imtiaz, S., Agic, B., Elton-Marshall, T., Hamilton, H. A. 0, Jiang, H., Mann, R. E, Sanches, M., Shield, K .D. Somé, N., Sornpaisarn, B., Nigatu, Y. T., Wickens, C. M, & Wettlaufer, A.
